XXII Company Profile and Key Details
22nd Century Group, Inc.
XXII Stock Price Chart
Stock Price Today
22nd Century Group, Inc. (XXII) stock declined over -17.61%, trading at $5.10 on NASDAQ, down from the previous close of $6.19. The stock opened at $6.50, fluctuating between $5.00 and $6.50 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Company Information
| Employees | 64 |
| Beta | 1.45 |
| Sales or Revenue | $32.20M |
| 5Y Sales Change% | -0.512% |
| Fiscal Year Ends | December |
| Sector | Consumer Defensive |
| Industry | Tobacco |
Frequently Asked Questions
22nd Century Group, Inc. (NASDAQ: XXII) stock price is $5.10 in the last trading session. During the trading session, XXII stock reached the peak price of $6.50 while $5.00 was the lowest point it dropped to. The percentage change in XXII stock occurred in the recent session was -17.61% while the dollar amount for the price change in XXII stock was -$1.09.
The NASDAQ listed XXII is part of Tobacco industry that operates in the broader Consumer Defensive sector. 22nd Century Group, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Peter F. Ferola
Chief Legal Officer & Sec.
Mr. John E. Franzino
Chief Admin. Officer
Mr. Steven P. Przybyla
Head of Hemp/Cannabis Bus. Devel.
Ms. Mei Kuo
Director of Communications & Investor Relations
Mr. James C. Morrison
Technical Advisor & Regulatory Affairs Consultant
Mr. R. Hugh Kinsman
Chief Financial Officer
Matthew Kreps
Investor Relations
Dr. Calvin Treat
Chief Scientific Officer
Mr. Sebastian Ravitz
Vice President of Marketing
Mr. John J. Miller
Interim Chief Executive Officer, Chief Operating Officer, Executive Officer & Pres of Tobacco Bus.
Mr. James A. Mish
Corporation Pres, Member of Scientific Advisory Board & Director
XXII's closing price is 30.77% higher than its 52-week low of $3.90 where as its distance from 52-week high of $581.85 is -99.12%.
Number of XXII employees currently stands at 64.
Official Website of XXII is: https://www.xxiicentury.com
XXII could be contacted at phone 716 270 1523 and can also be accessed through its website. XXII operates from 500 Seneca Street, Buffalo, NY 14204, United States.
XXII stock volume for the day was 715.91K shares. The average number of XXII shares traded daily for last 3 months was 871.97K.
The market value of XXII currently stands at $2.82M with its latest stock price at $5.10 and 553.52K of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com